Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101928269 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FOSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TREML3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LYPLA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM83G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF687 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCFC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF496 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01514 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLLP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRYL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on